Figure_4.tif (538.13 kB)
RSF1 amplification and relapse-free survival.
figure
posted on 2013-12-19, 03:31 authored by Dana Keilty, Marguerite Buchanan, Katerina Ntapolias, Olga Aleynikova, Dongsheng Tu, Xiao Li, Lois Shepherd, Vivien Bramwell, Mark BasikRFS for patients with RSF1 gene amplification or not, showing benefit from tamoxifen in both groups. Kaplan-Meier curves for RFS, tamoxifen vs. placebo in patients with RSF1 gene non-amplified (“low RSF1”) (A) and amplified (“high RSF1”) (B) tumors. Adjusted HRs are included for the comparison of tamoxifen vs. placebo in each group.
